ANDA 86394, held by Epic Pharma LLC. Triamcinolone Diacetate.
As of Nov 15, 2026, ANDA 86394 (Triamcinolone Diacetate), held by Epic Pharma LLC, was not approved, with 0 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Triamcinolone Diacetate40MG/ML ยท injectable;injection | Triamcinolone Diacetate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
